Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03381599 · ClinicalTrials.gov registry record · Phase 1
Stem Cells After Peripheral Mobilization and Harvest
A Phase 1 study, sponsored by Andrews Research & Education Foundation.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT03381599: Completed Phase 1 study, sponsored by Andrews Research & Education Foundation.
NCT03381599 is a Phase 1 study that has completed, run by Andrews Research & Education Foundation. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03381599, a Phase 1 study, has completed, sponsored by Andrews Research & Education Foundation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The proposed study is a controlled laboratory study where stem cell content of bone marrow aspirate will be compared prior to and following pharmaceutical mobilization. Participants who meet the inclusion/exclusion criteria will have a bone marrow sample taken from the iliac crest. The sample will be tested to determine stem cell content and for the presence of proteins which are of interest in orthopedic treatments. Thirty days following the baseline bone marrow collection, participants will receive a subcutaneous injection of Filgrastim daily for four serial days. On the fifth day, a peripheral blood sample will be taken and processed.
Primary Outcome
Quantity and quality of the harvested stem cells
Interventions
- DRUG Filgrastim Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-03-28 |
| Est. Completion | 2019-09-04 |
| Phase | Phase 1 |
What the finished NCT03381599 record still lists
NCT03381599 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which Filgrastim Injection is the first listed.
NCT03381599 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03381599 about?
NCT03381599 is a clinical study titled "Stem Cells After Peripheral Mobilization and Harvest". The proposed study is a controlled laboratory study where stem cell content of bone marrow aspirate will be compared prior to and following pharmaceutical mobilization. Participants who meet the inclusion/exclusion criteria will have a bone marrow sample taken from the iliac crest. The sample will b...
What is the current status of trial NCT03381599?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2018-03-28. Estimated completion is 2019-09-04.
What interventions are being tested in trial NCT03381599?
The interventions under investigation include: Filgrastim Injection (DRUG).
Who is sponsoring clinical trial NCT03381599?
This trial is sponsored by Andrews Research & Education Foundation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03381599's enrollment target sits among peer trials
10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI